Curiox BioSystems Co

Curiox BioSystems Co EBITDA per Share

The EBITDA per Share of Curiox BioSystems Co (445680.KQ) as of Oct 25, 2026 is -722.04 KRW. In the previous year, EBITDA per Share was -624.86 KRW — a change of 15.55% (lower).

EBITDA per Share

-722.04KRW

YoY

15.55%

Last updated:

EBITDA per Share of Curiox BioSystems Co is 2024 -722.04 KRW. EBITDA per Share of Curiox BioSystems Co was 2023 -624.86 KRW. It decreases by 15.55% lower compared to the previous year.

The Curiox BioSystems Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2021
-443.86 KRW
Jan 1, 2022
-619.71 KRW
Jan 1, 2023
-624.86 KRW
Jan 1, 2024
-722.04 KRW
The Curiox BioSystems Co EBITDA per Share history
YEAREBITDA per ShareYoY
-722.04KRW+15.55%
-624.86KRW+0.83%
-619.71KRW+39.62%
-443.86KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Curiox BioSystems Co Stock analysis

What does Curiox BioSystems Co do? Curiox BioSystems Co Ltd generates revenue through the manufacture and sale of automation equipment and consumables for cell analysis processes. The company offers cell pretreatment automation devices, washing machines, and plates, alongside high-capacity adapters, strip spacers, and buffer exchanger products. These products are sold to customers in the Life Sciences Tools & Services industry, primarily within the Korean market. The firm's focus on automation solutions for cell analysis drives its product portfolio and customer base. The company's product lines include cell pretreatment automation devices, washing machines, plates, high-capacity adapters, strip spacers, and buffer exchanger products. These items are designed for use in cell analysis processes, targeting clients who require efficient and precise laboratory equipment. The sales of these specialized tools form the core of Curiox BioSystems' revenue streams. Curiox BioSystems operates within the Life Sciences Tools & Services industry, focusing on providing automation solutions for cell analysis. Its products are manufactured and sold directly to end-users in the life sciences sector, including research institutions and laboratories. The company's revenue is derived from the direct sale of its equipment and consumables without intermediaries. Curiox BioSystems Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Curiox BioSystems Co stock

EBITDA per Share of Curiox BioSystems Co is -722.04 KRW in 2024.

EBITDA per Share of Curiox BioSystems Co changed from -624.86 KRW to -722.04 KRW, representing a 15.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Curiox BioSystems Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Curiox BioSystems Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Curiox BioSystems Co